Compared to Estimates, Pacific Biosciences (PACB) Q3 Earnings: A Look at Key Metrics

Pacific Biosciences of California (PACB) reported $38.44 million in revenue for the quarter ended September 2025, representing a year-over-year decline of 3.8%. EPS of -$0.12 for the same period compares to -$0.17 a year ago.The reported revenue represents a surprise of -3.51% over the Zacks Consensus Estimate of $39.84 million. With the consensus EPS estimate being -$0.16, the EPS surprise was +25%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street ...